Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

FRA/1SXP stock hub

FRA/1SXP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/1SXPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.4B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/1SXP

In the news

Latest news · FRA/1SXP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.1

P25 12.3P50 15.7P75 20.2

Trailing P/E15.7

P25 16.4P50 20.9P75 30.4

ROE17.1

P25 -6.7P50 8.5P75 17.2

ROIC12.1

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/1SXP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

EUR

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	4,829
Employees Change	121%
Employees Change Percent	2.58
Enterprise value	EUR 2.7B
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	DE000A3ENQ51
Last refreshed	2026-05-10
Market cap	EUR 2.4B
Price	EUR 15.48
Price currency	EUR
Rev Per Employee	206,053.01x
Sector	Healthcare
Sic	3221
Symbol	fra/1SXP
Website	https://www.schott-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.37%
EV Earnings	17.85x
EV/EBIT	13.17x
EV/EBITDA	9.37x
EV/FCF	230.9x
EV/Sales	2.69x
FCF yield	0.49%
Forward P/E	16.06x
P/B ratio	2.52x
P/E ratio	15.69x
P/S ratio	2.36x
PE Ratio3 Y	28.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.9%
EBITDA Margin	26.62%
FCF margin	1.17%
Gross margin	33.64%
Gross Profit	EUR 334.7M
Gross Profit Growth	5.82%
Gross Profit Growth Q	2.94%
Gross Profit Growth3 Y	13.96%
Net Income	EUR 149.9M
Net Income Growth	11.1%
Net Income Growth Q	11.76%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	14.17%
Pretax Margin	19.39%
Profit Margin	15.07%
Profit Per Employee	EUR 31,051
Profitable Years	6
ROA	7.57
Roa5y	9.37
ROCE	15.87
ROE	17.06
Roe5y	21.86
ROIC	12.09
Roic5y	17.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-37.56%
EPS Growth	10.01
EPS Growth Q	10
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	13.93
FCF Growth	-74.87%
FCF Growth3 Y	-30.23%
OCF Growth	-13.92%
OCF Growth Q	-86.44%
OCF Growth3 Y	6.17%
Revenue Growth	4.06x
Revenue Growth Q	3.81x
Revenue Growth Quarters	4x
Revenue Growth Years	5x
Revenue Growth3 Y	15.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.64
Assets	EUR 1.6B
Cash	EUR 24.6M
Current Assets	EUR 699M
Current Liabilities	EUR 442.7M
Debt	EUR 346.9M
Debt EBITDA	EUR 1.28
Debt Equity	EUR 0.37
Debt FCF	EUR 29.92
Equity	EUR 932.3M
Interest Coverage	10.19
Liabilities	EUR 695.5M
Long Term Assets	EUR 928.8M
Long Term Liabilities	EUR 252.7M
Net Cash	EUR -322.4M
Net Cash By Market Cap	EUR -13.7
Net Debt EBITDA	EUR 1.22
Net Debt Equity	EUR 0.35
Net Debt FCF	EUR 27.8
Tangible Book Value	EUR 900.4M
Tangible Book Value Per Share	EUR 5.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.58
Inventory Turnover	3.94
Net Working Capital	EUR 500.2M
Quick ratio	0.7
Working Capital	EUR 256.3M
Working Capital Turnover	EUR 4.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.18%
Dividend Growth	12.5%
Dividend Growth Years	2%
Dividend per share	EUR 0.18
Dividend Years	3
Dividend Yield	1.17%
Ex Div Date	2026-02-04
Last Dividend	EUR 0.18
Payout Frequency	Annual
Payout Ratio	16.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-37.54%
200-day SMA	17.83
50-day SMA	14.2
50-day SMA vs 200-day SMA	50under200
All Time High	43.2
All Time High Change	-64.17%
All Time High Date	2024-02-29
All Time Low	12.68
All Time Low Change	22.08%
All Time Low Date	2026-03-23
ATR	0.29
Ch YTD	2.38
High	15.48
High52	30.1
High52 Date	2025-06-16
High52ch	-48.57%
Low	15.32
Low52	12.68
Low52 Date	2026-03-23
Low52ch	22.08%
Ma50ch	9.05%
Price vs 200-day SMA	-13.17%
RSI	62.39
RSI Monthly	36.04
RSI Weekly	45.58
Sharpe ratio	-1.36x
Sortino ratio	-1.71
Total Return	-0.01%
Tr YTD	3.69
Tr1m	12.17%
Tr1w	4.17%
Tr3m	8.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 188.1M
Operating Income Growth	5.74
Operating Income Growth Q	6.4
Operating Income Growth3 Y	17.99
Operating margin	18.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,641,362%
Net Borrowing	13,060,000
Shares Institutions	18.25%
Shares Qo Q	-0.03%
Shares Yo Y	1.18%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 11.6M
Average Volume	251.9x
Bv Per Share	6.17
CAPEX	EUR -146.7M
Ch1m	12.17
Ch1w	4.17
Ch1y	-38.33
Ch3m	8.86
Ch6m	-14.48
Change	0%
Change From Open	1.04
Close	15.48
Days Gap	-1.03
Depreciation Amortization	76,784,000
Dollar Volume	464.4
Earnings Date	2026-05-13
EBIT	EUR 188.1M
EBITDA	EUR 264.9M
EPS	EUR 0.99
F Score	6
FCF	EUR 11.6M
FCF EV Yield	0.43x
Financing CF	-7,128,000
Fiscal Year End	September
Founded	1,884
Graham Number	11.66978
Graham Upside	-24.61
Income Tax	EUR 42.5M
Investing CF	-143,168,000
Is Primary Listing	0
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Lynch Fair Value	EUR 13.98
Lynch Upside	-9.68
Ma150	16.13
Ma150ch	-4.04%
Ma20	14.87
Ma20ch	4.14%
Net CF	7,809,000
Next Earnings Date	2026-05-13
Open	15.32
P FCF Ratio	202.9
P OCF Ratio	14.87
Payment Date	2026-02-06
Position In Range	100
Ppne	792,352,000
Price Date	2026-05-08
Price EBITDA	EUR 8.88
Ptbv Ratio	2.61
Relative Volume	0.12x
Revenue	995,030,000x
Tax By Revenue	4.27x
Tax Rate	22.02%
Tr6m	-13.38%
Volume	30
Z Score	4.45

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/1SXP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.18 annual per share

Payout ratio

+16.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

-0.0%

Next ex-dividend date: 2026-02-04

Performance

FRA/1SXP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/1SXP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.2%

Negative means the company is buying back shares.

Technical

FRA/1SXP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.4

Neutral momentum band

Price vs 200-day MA

-13.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/1SXP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/1SXP stock rating?

fra/1SXP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/1SXP analysis?

The full report lives at /stocks/fra/1SXP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/1SXP?

The latest report frames fra/1SXP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/1SXP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.